Inhibition of the Mitochondrial Pyruvate Carrier Simultaneously Mitigates Hyperinflammation and Hyperglycemia in COVID-19

Scientists showed that genetic ablation or pharmacological inhibition of mitochondrial pyruvate carrier attenuated severe disease following influenza or SARS-CoV-2 pneumonia.